The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Associations of Serum Osteoprotegerin Levels with Diabetes, Stroke, Bone Density, Fractures, and Mortality in Elderly Women1
Open accessAbstract
Osteoprotegerin (OPG) and its ligand are cytokines that regulate osteoclastogenesis and that may be involved in the regulation of vascular calcification. We examined whether serum OPG levels were associated with stroke, mortality, and cardiovascular risk factors, including diabetes, as well as with bone mineral density and fractures in a sample of 490 participants in a prospective cohort of white women, at least 65 yr of age. We found that OPG levels, assayed blinded from serum obtained at baseline, were about 30% greater in women with diabetes (mean ± sd, 0.30 ± 0.17 ng/mL) than in those without diabetes (0.23 ± 0.10 ng/mL; P= 0.0001). OPG levels were associated with all-cause mortality[ age-adjusted odds ratio, 1.4/sd (0.11 ng/mL) increase in serum OPG level; 95% confidence interval, 1.2–1.8] and cardiovascular mortality (odds ratio, 1.4; 95% confidence interval, 1.1–1.8); these effects were not confounded by diabetes. OPG levels were not associated with baseline bone mineral density or with subsequent strokes or fractures. The association of serum OPG levels with diabetes and with cardiovascular mortality raises the possibility that OPG may be a cause of or a marker for vascular calcification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Self-citationOPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., & Karsenty, G. (1997) · Nature · doi:10.1038/386078a0 · Cited by 2,120
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,173
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775
Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis
Stern, M. P. (1995) · Diabetes · doi:10.2337/diab.44.4.369 · Cited by 739
Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
Cummings, S. R., Browner, W. S., Bauer, D., Stone, K., Ensrud, K., Jamal, S., & Ettinger, B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391104 · Cited by 660
Self-citationParhami, F., Morrow, A. D., Balucan, J., Leitinger, N., Watson, A. D., Tintut, Y., Berliner, J. A., & Demer, L. L. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.680 · Cited by 619
Lehto, S., Niskanen, L., Suhonen, M., Rönnemaa, T., & Laakso, M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.978 · Cited by 594
Min, H., Morony, S., Sarosi, I., Dunstan, C. R., Capparelli, C., Scully, S., Van, G., Kaufman, S., Kostenuik, P. J., Lacey, D. L., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.463 · Cited by 550
Axial and appendicular bone density predict fractures in older women
Black, D. M., Cummings, S. R., Genant, H. K., Nevitt, M. C., Palermo, L., & Browner, W. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070607 · Cited by 510
Self-citationTakahashi, N., Udagawa, N., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0252 · Cited by 463
Calcification of Vascular Smooth Muscle Cell Cultures: Inhibition by Osteopontin
Wada, T., McKee, M. D., Steitz, S., & Giachelli, C. M. (1999) · Circulation Research · doi:10.1161/01.res.84.2.166 · Cited by 458
Yano, K., Tsuda, E., Washida, N., Kobayashi, F., Goto, M., Harada, A., Ikeda, K., Higashio, K., & Yamada, Y. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.4.518 · Cited by 363
Yun, T. J., Chaudhary, P. M., Shu, G. L., Frazer, J. K., Ewings, M. K., Schwartz, S. M., Pascual, V., Hood, L. E., & Clark3, E. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6113 · Cited by 307
Towler, D. A., Bidder, M., Latifi, T., Coleman, T., & Semenkovich, C. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30427 · Cited by 246
Giachelli, C. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65313-8 · Cited by 243
Osteopontin Expression in Cardiovascular Diseasesa
GIACHELLI, C. M., LIAW, L., MURRY, C. E., SCHWARTZ, S. M., & ALMEIDA, M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44624.x · Cited by 181
Biochemical Markers of Bone Turnover for the Clinical Assessment of Metabolic Bone Disease
Delmas, P. D. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30336-0 · Cited by 172
Recent advances in bone biology provide insight into the pathogenesis of bone diseases.
Boyce, B. F., Hughes, D. E., Wright, K. R., Xing, L., & Dai, A. (1999) · PubMed · Cited by 145
Thiede, M. A., Smock, S. L., Petersen, D. N., GRASSER, W. A., Thompson, D. D., & Nishimoto, S. K. (1994) · Endocrinology · doi:10.1210/endo.135.3.8070388 · Cited by 138
The Mystery of Diabetes and Atherosclerosis: Time for a New Plot
Semenkovich, C. F., & Heinecke, J. W. (1997) · Diabetes · doi:10.2337/diab.46.3.327 · Cited by 120
Atherosclerotic calcification: Relation to developmental osteogenesis
Boström, K. I., Watson, K. E., Stanford, W. P., & Demer, L. L. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)80020-s · Cited by 116
Diabetes and Cardiovascular Disease
Johnstone, M. T., & Veves, A. (2001) · Humana Press eBooks · doi:10.1385/1592590918 · Cited by 106
Increasing serum osteocalcin after glycemic control in diabetic men
Sayinalp, S., Gedik, O., & Koray, Z. (1995) · Calcified Tissue International · doi:10.1007/bf00301944 · Cited by 65
The role of osteoprogenitors in vascular calcification
Jakoby, M., & Semenkovich, C. F. (2000) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200001000-00003 · Cited by 47
Atherosclerosis in amputated legs of patients with and without diabetes mellitus.
Mozes, G. I., KERESZTURY, G., Kádár, A. Z., Magyar, J., Sipos, B., Dzsinich, S., & Gloviczki, P. (1998) · PubMed · Cited by 36
The atherosclerosis–calcification link?
Watson, K. E., & Demer, L. L. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199604000-00009 · Cited by 28
Trends in Molecular Medicine: Molecular determinants of arterial calcification
Schinke, T., McKee, M. D., Kiviranta, R., et al. (1998) · Annals of Medicine · doi:10.3109/07853899709002601 · Cited by 27
Cited by
Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases
Hofbauer, L. C. (2004) · JAMA · doi:10.1001/jama.292.4.490 · Cited by 988
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Vascular Calcification: Mechanisms and Clinical Ramifications
Abedin, M., Tintut, Y., & Demer, L. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000133194.94939.42 · Cited by 863
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Theoleyre, S., Wittrant, Y., Tat, S. K., Fortun, Y., Redini, F., & Heymann, D. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.06.004 · Cited by 663
Metadata
- Authors
- Browner, W. S., Lui, L.-Y., & Cummings, S. R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-02-01
- Volume
- 86
- Issue
- 2
- Pages
- 631-637
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2128791904
- Cited by
- 506
- References
- 33
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.